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Abstract 
 
Aim: To examine the occurrence of intra-left ventricular (LV) dyssynchrony in obese versus non-obese 
subjects without known cardiac disease using velocity vector imaging (VVI). 
 
Methods: One hundred ninety consecutive subjects with no known cardiac disease had their 
echocardiograms analyzed using VVI after excluding subjects with QRS duration >120ms or LV ejection 
fraction (LVEF) <55%. Study subjects were divided into two groups based on body mass index (BMI): 
obese (BMI >30 kg/m2) and non-obese (BMI <30 kg/m2).  
 
Results: The final cohort included 136 subjects (74 were obese), 32% female and mean age 55 + 16 years. 
Occurrence of intra LV dyssynchrony was higher in the obese compared to non-obese group. 
 
Conclusions: There was an increased prevalence of intra LV dyssynchrony in obese subjects, especially 
longitudinal and radial dyssynchrony. This dyssynchrony may signal a mechanism by which obesity 
predisposes to the development of heart failure. 
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Obesity is a modern epidemic, with greater than 60 million adults affected in the United States alone.1 
Obesity is an important risk factor for heart failure in both men and women. Increased body mass index 
(BMI) has been reported in 11% and 14% of heart failure cases in men and women, respectively2. Left 
ventricular hypertrophy and dilatation1, 3-5, which are known precursors of heart failure6, 7 are associated with 
obesity. Also, obesity is associated with altered LV remodeling, possibly due to increased hemodynamic 
load, neurohormonal activation and increased cytokine production8. Myocardial triglyceride content appears 
to increase progressively with body mass index9. Recent experimental investigations suggest cardiac 
steatosis (excessive accumulation of cytosolic triglycerides in the myocardial cells), increased myocardial 
fibrosis, lipoapoptosis, and the activation of certain cardiac genes may underlie obesity cardiomyopathy10, 11. 
Recent studies using positron emission tomography found that in obese young women, insulin resistance and 
obesity are related to alterations in fatty acid metabolism, which could play a role in decreased cardiac 
performance11-15. Whatever these intricate and complex molecular mechanisms may be, evidence suggests 
that long standing obesity results in LV structural and functional alterations producing volume overload, 
eccentric LV hypertrophy, systolic and diastolic dysfunction and heart failure16. 
 
Marfella and associates demonstrated a higher occurrence of interventricular dyssynchrony in obese subjects 
using 2-dimensional (2-D) echocardiography with Doppler17. To our knowledge there have been no studies 
thus far examining the incidence of intra LV dyssynchrony in obese subjects who do not have a history of 
significant cardiac disease.  
 
Myocardial contraction and relaxation are complex processes involving longitudinal, circumferential, radial 
and tortional forces. Velocity vector imaging (VVI) is a novel technique that uses myocardial speckle 
tracking to assess myocardial mechanics from 2-D echocardiography18. VVI uses an algorithm that 
automatically tracks motion of the tissue/cavity border and motion of reference points (mitral annulus), 
displaying tissue motion, direction and velocity (Figure 1). Unlike tissue Doppler imaging (TDI), VVI 
measures velocities independent of transducer angle. Also, in a recent study, Lim et al., demonstrated that 
the accuracy of TDI in assessing LV wall regional motion is limited in dilated ventricles and probably 
affects LV dyssynchrony measurement19. 
 
Our aim was to examine the prevalence of intra LV dyssynchrony in obese subjects who have no history of 
cardiac disease and compare them with non-obese controls using VVI. 
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Methods: 
 
Five hundred consecutive subjects who had their 2-D echocardiograms performed at Albert Einstein Medical 
Center, Philadelphia between November 2008 and March 2009 on an Acuson Sequoia C512 (Sequoia, 
Siemens Medical Solutons Inc., Mountain View, California20) were screened. 310 subjects were excluded 
with the following exclusion criteria: 1) history of coronary artery disease; 2) left ventricular ejection 
fraction (LVEF) < 55%; 3) diastolic dysfunction greater than grade 1 (mitral early to late diastolic inflow 
peak velocity ratio > 0.8, deceleration time of the mitral inflow < 200ms, isovolumetric relaxation time < 
60ms, pulmonary venous systolic to diastolic peak velocity ratio < 1 and mitral early inflow to early diastolic 
annular septal tissue peak velocity ratio > 9 as listed in American Society of Echocardiography criteria21) ; 4) 
QRS duration > 120ms; 5) moderate or severe valvular heart disease (using Doppler echocardiographic 
parameters-central jet > 4cm2 or jet area > 20% of left atrial area for mitral regurgitation, central jet width > 
25% or vena contracta > 0.3cm2 or pressure half time < 500ms for aortic regurgitation, central jet area > 5cm 
or proximal isovelocity surface radius > 0.5cm for tricuspid regurgitation, jet size by color Doppler > 10mm 
for pulmonary regurgitation-for regurgitant lesions22; mean gradient > 20 mm of Hg or aortic valve area of < 
1.5cm2 or aortic jet velocity of > 3m/s for aortic stenosis, mitral valve area < 1.5cm2 or mean gradient of > 
5mm of Hg for mitral stenosis, tricuspid valve area < 1cm2 or mean gradient > 5mm of Hg or inflow time-
velocity time integral > 60cm or pressure half time > 190ms for tricuspid stenosis, peak velocity > 3m/s or 
peak gradient > 36mm of Hg for pulmonic stenosis-for stenotic lesions23) ; 6) pacemaker; 7) hypertrophic 
cardiomyopathy; 8) pericardial effusion or disease; 9) poor quality images where the myocardium was not 
visible and; 10) any subject admitted to the intensive care unit. Subjects were divided into two groups based 
on body mass index (BMI): 1) BMI of greater than or equal to 30 kg/m2 (obese) and 2) BMI less than 30 
kg/m2 (non-obese). We also compared morbidly obese subjects (BMI of greater than or equal to 40kg/m2) to 
obese subjects (BMI ≥ 30 to <40).  
 
VVI was performed using the Acuson Sequoia C512. Images were captured using frame rates used for 
traditional 2-D echocardiograms (30-60 frames/sec.). VVI uses a series of tracking algorithms whose details 
are described elsewhere18. In brief, the endocardial-myocardial interface is traced manually in a single frame 
on a digital cine-loop. When the image is processed, a complex algorithm tracks each pixel and the 
myocardial velocity vectors are displayed in cine format. The lengths of the vectors are proportional to the 
magnitude of velocity and the direction of the arrows corresponds to the direction of myocardial motion. 
One cardiac cycle was analyzed if the RR intervals were regular, and an average of 3 beats was used if RR 
intervals were irregular. Apical four chamber, two chamber and short axis views at the papillary muscle level 
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were studied off-line. In the apical four and two chamber views, a trace was made (along the endocardial-
myocardial interface) from the septal to lateral mitral annulus and from the inferior to anterior mitral annulus 
respectively. In the short axis view at the level of papillary muscles, a circumferential trace was made 
starting at 12 o’clock position and ending at the same point in a clockwise direction, excluding the papillary 
muscles. Approximately one point per myocardial segment was used to draw the trace. A point of reference 
was placed at the apex in the two and four chamber views to calculate longitudinal velocities and strain. The 
point of reference was moved to the left ventricular cavity to calculate radial velocities. In the short axis 
view, the point of reference was at the center of the left ventricle to calculate circumferential velocities and 
strain. Longitudinal velocity, longitudinal strain and radial velocities were measured at the basal septal, basal 
lateral, basal anterior and basal inferior walls in the apical four and two chamber views.  The circumferential 
velocities and strain were measured in the short axis view at the papillary muscle level. Time to peak 
velocities and strain were calculated from the onset of the QRS complex to the peak systolic velocity or peak 
strain respectively during the ejection phase. We defined mechanical dyssynchrony as longitudinal opposing 
wall delay >75 ms by VVI based on a prior study24. As there are no published criteria for circumferential 
dyssynchrony and since we were looking at the maximum delay between all 6 segments in the short axis 
view, not just the opposing wall delays, we used a higher number (maximum delay ≥ 100 ms) to define 
circumferential dyssynchrony. We used a value of 75 ms for septal to lateral wall radial delay. An example 
of longitudinal and circumferential LV dyssynchrony analysis using the above mentioned VVI technique is 
illustrated in figures 2 and 3, respectively. 
 
Patient demographics, clinical characteristics, hemodynamic measurements, laboratory data, 
echocardiographic parameters and electrocardiographic data were collected (Tables 1 and 2). Patient 
demographics collected were age, gender and race. Clinical characteristics collected were any history of 
hypertension (blood pressure > 140/90mm of Hg as defined by the 7th report of the ‘Joint National 
Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure’25 or if they are on 
anti-hypertensives), diabetes mellitus (fasting plasma glucose > 126mg/dl as per the ‘American Diabetes 
Association’26 or if they are on anti-diabetes treatment), prior history of transient ischemic attack27, ischemic 
stroke28 or intracranial hemorrhage, hypercholesterolemia (low density lipoprotein levels > 130mg/dl as per 
‘National Cholesterol Education Program’ report29 or if they are on a HMG CoA  reductase inhibitor), a 
diagnosis of obstructive sleep apnea30 , a diagnosis of stable chronic obstructive pulmonary disease31 and 
whether the subjects were on hemodialysis. Hemodynamic measurements recorded were heart rate and 
systolic and diastolic blood pressure recorded immediately prior to performing the echocardiogram. 
Laboratory data obtained were hemoglobin and creatinine, which were done closest to the time of the 
echocardiogram. QRS duration was recorded from the electrocardiogram. All echocardiographic 
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measurements were based on ASE guidelines. Left ventricular diastolic dimension (LVIDd), septal wall 
thickness (SWT), posterior wall thickness (PWT), left atrial diameter and LV mass were measured using 2D-
guided M-mode, assuming that the LV is a prolate ellipse in the parasternal long-axis acoustic window32. LV 
mass was indexed to body surface area. Diastolic dysfunction and the grade of dysfunction21, LVEF (was 
calculated using the modified Simpson’s rule32) and pulmonary artery systolic pressures33 were measured. 
 
The study was approved by the institutional research board of Albert Einstein Medical Center, Philadelphia.  
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Statistical Analysis: 
 
Data were analyzed using the SPSS 10 (Chicago, IL, USA). Continuous data are presented as mean ± SD. 
Means were compared using a two-tailed student t test. Multivariate analysis was performed using the 
regression model. Chi-square test was used to compare categorical variables. A p value less than 0.05 were 
considered significant. Co-efficient of variation (COV) was used to measure the inter and intra-observer 
variability on 20 random obese and non-obese subjects.  
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Results: 
The final cohort consisted of 136 subjects. Thirty subjects were excluded from the obese group and 24 from 
the non-obese group. Among the 30 excluded obese subjects, 17 were excluded due to incomplete data and 
13 due to poor quality echocardiograms. Among the 24 excluded non-obese subjects, 15 were excluded due 
to incomplete data and 9 due to poor quality echocardiograms. In the final cohort, 74 were obese subjects 
and 62 were non-obese controls. Mean age was 55 ± 16 years, 32% were female, mean QRS duration was 84 
± 9 ms and mean LVEF was 60 ± 8%. Of note, no subject had a LVEF < 55%, while others were more 
hyperdynamic. Demographic and clinical data were well matched between the two groups (Table 1). 
Echocardiographic, hemodynamic and electrocardiographic parameters are reported in Table 2. Among the 
72 obese subjects, 50 (68%) had a BMI between 30 to 40 and 24 (32%) had a BMI ≥ 40 (morbidly obese). 
The inter and intra-observer variability was calculated for all the different VVI measurements done in the 
study for the 20 random obese and non-obese subjects. The COV for longitudinal, radial and circumferential 
time to peak velocities were 5%, 6% and 6%, respectively for inter-observer variability; 5%, 5% and 6%, 
respectively for intra-observer variability. The COV for longitudinal and circumferential strain were 8% and 
8%, respectively for inter-observer variability; 7% and 8%, respectively for intra-observer variability.   
 
Velocity Vector Analysis (Table 3) 
a) Longitudinal  velocity  
Among the obese subjects, 9.4% (n=7) had a longitudinal septal to lateral (S-L) wall time to peak delay of 
>75ms whereas, 0% of the non-obese subjects had evidence of dyssynchrony (p=0.01). There were no 
significant differences in the longitudinal absolute peak velocities of the basal myocardial walls (measured in 
the apical 2 chamber and 4 chamber views) between the two groups (obese and non-obese). 
b) Radial velocity 
Among the obese subjects, 31.0 % (n=23) had a radial septal to lateral (S-L) wall time to peak delay of 
>75ms as compared to 8.0% (n=5) among non-obese subjects (p< 0.01). There were no significant 
differences in the radial absolute peak velocities of the basal myocardial walls (measured in the apical 2 
chamber and 4 chamber views) between the two groups. 
c) Circumferential velocity 
Among the obese subjects, 27.0% (n=20) had a maximum opposing wall time to peak circumferential delay 
of > 100ms compared to 1.6% (n=1) among non-obese subjects (p< 0.01). There were no significant 
differences in the circumferential absolute peak velocities between the obese and non-obese subjects. 
 
Strain Analysis 
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a) Longitudinal Strain 
Among the obese subjects, 58.1% (n=43) had a maximum opposing wall time to peak delay in longitudinal 
strain of > 100ms compared to 33.8% (n=21) among non-obese subjects (p<0.01). There were no significant 
differences in the longitudinal strain between the two groups. 
b) Circumferential Strain  
Among the obese subjects, 10.8% (n=8) had a maximum opposing wall time to peak delay in circumferential 
strain of > 100ms as compared to 1.6% (n=1) among non-obese subjects (p=0.03). There were no significant 
differences in circumferential peak strain between the obese and non-obese subjects. 
 
Comparison Between Obese and Non-Obese Groups 
There was significantly increased time to peak delay in longitudinal, radial and circumferential velocities 
and delay in time to peak longitudinal and circumferential strain in obese subjects when compared to non-
obese subjects (Table 4). Obese subjects had a higher LVIDd, LV mass, QRS duration, systolic and diastolic 
blood pressures (but all still within normal reference limits), when compared to the non-obese subjects. Even 
after adjusting for these confounding variables, in addition to age, race, gender, LV mass index and LVEF, 
the obese subjects had a significantly increased LV dyssynchrony when compared to the non-obese subjects 
on a multivariate analysis (Table 5).  
 
Comparison of Dyssynchrony between Obese and Morbidly Obese groups (Table 6) 
There were no significant differences in longitudinal, radial and circumferential time to peak velocities and 
time to peak longitudinal and circumferential strain or myocardial peak velocities and peak strain between 
obese and morbidly obese subjects.  
 
Comparison of LVEF between obese subjects with and without dyssynchrony (Figure 4) 
Obese subjects with time to peak delay in longitudinal septal to lateral wall velocity of >75ms had a lower 
LVEF (55 ± 0%) when compared to obese subjects with time to peak longitudinal S-L wall delay of <75ms 
(60 ± 7%; p<0.01).  Obese subjects with time to peak delay in radial S-L wall velocity >75ms, delay in time 
to peak circumferential velocity >100ms or delay in time to peak longitudinal and circumferential strain had 
similar LVEF when compared to non-obese subjects.  
 
Comparison of LVEF between obese and non-obese subjects with dyssynchrony 
The LVEF was lower in the obese group when compared to the non-obese group among the subjects with a 
longitudinal strain maximum opposing wall delay >100ms (59 + 6% vs. 62ms + 8%; p>0.05), radial septal-
lateral wall delay >75ms (59 + 7% vs. 63 + 9%; p>0.05) and radial maximum opposing wall delay >100ms 
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(60 + 7% vs. 61 + 9%; p>0.05).  There were very few non-obese subjects with longitudinal, circumferential 
and circumferential strain dyssynchrony (table 3.) to make a statistically appropriate comparison. 
 
Subjects with QRS duration >100ms 
Seven study subjects had QRS duration >100ms; six were obese.  When comparing dyssynchrony between 
subjects with QRS duration >100ms and those with QRS duration <100ms, only longitudinal strain septal-
lateral wall delay was increased (86.43 + 39.97ms vs. 48.56 + 72.14ms; p<0.05). 
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Discussion: 
 
Multiple parameters of intra LV dyssynchrony, including radial and longitudinal dyssynchrony, were more 
frequent in obese subjects when compared to non-obese subjects. After multivariate analysis, obesity 
remained a significant independent predictor of intra LV dyssynchrony. Interestingly, there were no 
significant differences in the peak myocardial velocities or peak myocardial strain between obese and non-
obese subjects. 
 
Obesity is associated with left ventricular hypertrophy and dilatation1, 3-5; known precursors of heart failure6, 
7
. Obesity is associated with altered LV remodeling, possibly due to increased hemodynamic load, 
neurohormonal activation and increased cytokine production8. There is very little data examining ventricular 
dyssynchrony in obese subjects. One study by Marfella et al., in 2004 described interventricular 
dyssynchrony among premenopausal obese women, which improved significantly after a 10% weight loss17. 
They used pulmonary vein flow analysis, E/A ratios (ratio of mitral early and late diastolic flow velocities) 
and myocardial performance index (MPI= [isovolumetric relaxation time + isovolumetric contraction 
time]/left ventricular ejection time) to assess interventricular dyssynchrony. Tumuklu et al., suggested that 
decreased regional strain rate seen in obese, compared to the non-obese subjects, was a reflection of 
subclinical changes in LV systolic function34. However, they did not study dyssynchrony between these two 
groups.   
 
Ten Harkel et al., investigated intra LV dyssynchrony and LV volumes in 73 healthy adolescents (age range 
of 12 – 18 years) using real-time three-dimensional echocardiography35. In contrast to the present study, they 
found dyssynchrony values were independent of weight, length and body surface area. However, there were 
significant differences in these study populations. In the present study, subjects were older than the 
adolescents (55 versus 15 years old). Further, Ten Harkel et al., did not report the proportion of adolescents 
who were overweight or obese, therefore making it difficult to assess the association of obesity and intra LV 
dyssynchrony. On similar lines, Ng and et al., prospectively investigated the impact of age, gender and other 
physiological parameters on LV longitudinal and radial synchrony using TDI and 2-dimensional speckle 
tracking and found that dyssynchrony was independent of BMI36. The mean BMI of the study group was 
25.8 + 4.9, and the proportion of obese subjects was not reported. Therefore, it is difficult to arrive at any 
conclusions with regards to obesity and LV dyssynchrony based on these prior studies. 
 
Bernheim et al., found that patients with normal, clinically indicated exercise echocardiograms (LVEF 
>50%) and QRS duration <120ms, who had abnormal dyssynchrony parameters at rest had a higher resting 
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heart rate and achieved a lower workload37. They felt that this indicated early myocardial impairment. Chang 
et al., found that LV systolic and diastolic dyssynchrony in asymptomatic patients with hypertension who 
had a QRS duration <120ms and normal range LVEF were significantly associated with LV filling 
pressure38. In view of the above studies and with the results of our study, intra LV dyssynchrony may play a 
role in the mechanisms underlying heart failure development in obese subjects.  
 
Myocardial triglyceride content appears to increase progressively with body mass index9. Experimental 
investigations suggest that this cardiac steatosis (excessive accumulation of cytosolic triglycerides in the 
myocardial cells), increases myocardial fibrosis and lipoapotosis and may underlie obesity 
cardiomyopathy10, 11. Rijzewijk et al., demonstrated that myocardial steatosis is an independent predictor of 
diastolic dysfunction in patients with type 2 diabetes mellitus39 and Kankaanpää et al., showed that the free 
fatty acid levels were significantly correlated with LV mass40. These studies applied magnetic resonance 
imaging and spectroscopy techniques to quantify myocardial triglyceride content. However, quantification of 
regional differences of triglyceride content in the myocardium is difficult as the heart is perpetually in 
motion and is surrounded by a large depot of adipocytes (epicardial fat pad) that interferes with 
measurements41. Thus, whether regional variations in myocardial steatosis exist and plays a role in the 
observed dyssynchrony in obese patients requires further study. Of note, the obese subjects in the present 
study had an increased LV mass, LVIDd, PWT, blood pressure, and QRS duration when compared to the 
non-obese subjects. However, these confounding variables did not influence our results after multivariate 
analysis (Table 4).  
 
As mentioned earlier, we found no differences in the peak velocities and strain achieved by the different 
myocardial walls between obese and non-obese subjects. Contrary to our study, Tumuklu et al., using 
reconstructed spectral pulsed wave tissue Doppler showed significantly decreased myocardial peak 
velocities, regional and global strain among obese subjects when compared to non-obese controls34. The 
present study was cross-sectional so that we could not test the possibility of dyssynchrony preceding changes 
in peak velocities and strain.  Further, dyssynchrony looks at the difference in the time taken to achieve peak 
velocities or strain between opposing walls and not at the absolute velocities or strain and changes in these 
different parameters need not simultaneously occur. 
 
Contrary to the existing literature, there were fewer obese subjects in our study with obstructive sleep apnea 
and elevated pulmonary artery pressures. This could be explained by the fact that our study was retrospective 
and many of our subjects had not yet had a sleep study. Thus the reported number of subjects with 
obstructive sleep apnea is observational in this population. It is likely that the number of obese subjects with 
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obstructive sleep apnea is underestimated. Given the fact that we excluded subjects who had moderate or 
severe tricuspid regurgitation, low LVEF, diastolic dysfunction greater than grade 1 or those who were 
admitted to the intensive care unit, several obese subjects with elevated pulmonary artery pressures were 
excluded.  
   
Our study raises multiple questions and possibilities regarding the occurrence of dyssynchrony in obese 
subjects and its role in the causation of systolic dysfunction in obese subjects. With obesity being a rising 
worldwide epidemic, and with its harmful effects on cardiac function, and contribution to heart failure, 
further studies are warranted. It would also be interesting to see if obese individuals are better cardiac re-
synchronization therapy responders than their non-obese counterparts, as we see an increased occurrence of 
dyssynchrony among obese subjects. 
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Limitations: 
 
This is a retrospective study limited to an inner city single medical center. Since a lower frame rate was used 
for VVI, it is conceivable that some very rapid velocities may not be recorded. Nevertheless, comparison 
between the time to peak velocities between two walls should remain valid.   Some MRI studies looking at 
the heterogeneity in LV contraction used frame rates ranging from 14 – 35 ms. This is comparable with the 
30-60 f/s (16 – 33 ms) used in this study. Unlike speckle tracking echocardiography, which can measure 
radial strain in the short axis views42, VVI cannot measure these radial velocities in the short axis view and 
LV torsion that could have given us more information about LV function. Waist to hip ratio was not 
calculated as these were not standard measurements for subjects who underwent echocardiography. Waist to 
hip ratio is a stronger correlate of LV dysfunction and mortality when compared to BMI43. As this was a 
retrospective study, we could not accurately estimate the duration of obesity for each subject and therefore 
assess its effect on dyssynchrony.  As this was not a longitudinal study and clinical effects were not 
measured, these findings should be viewed as thought provoking with future studies assessing the potential 
contribution of intra LV dyssynchrony in obese subjects with clinical endpoints such as heart failure. 
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Conclusions:  
 
There was increased intra LV dyssynchrony among obese subjects when compared to non-obese subjects, 
especially longitudinal and radial dyssynchrony. This dyssynchrony may signal one mechanism by which 
obesity predisposes to the development of heart failure. 
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 Figure legends: 
 
Figure 1. Myocardial velocity vector imaging. The figure shows the VVI with myocardial velocity vectors. 
The direction of the arrows represents the direction of contraction and the length of the arrow is proportional 
to myocardial velocity. Top right: Myocardial velocity curves. Bottom right: M-mode representation of 
dyssynchrony with the red phase representing systole and the blue phase representing diastole. 
 
Figure 2. An example of longitudinal LV dyssynchrony analysis using the velocity vector imaging (VVI) 
technique. The figure shows a longitudinal VVI analysis. Top left: Myocardial longitudinal velocity vectors 
are shown. Bottom left: Longitudinal velocity curves for basal septal and basal lateral myocardial walls are 
shown. Top right: The time to peak longitudinal velocities of the basal septal (base left) and basal lateral 
(base right) walls are measured in this view. In this analysis, the longitudinal septal to lateral wall delay is 
34ms. 
 
Figure 3. An example of circumferential LV dyssynchrony analysis using the VVI technique. The figure 
shows the circumferential VVI analysis of an obese subject. Top left: Myocardial circumferential velocity 
vectors are shown. Bottom left: Circumferential velocity curves for the various myocardial segments seen in 
the short axis view at the level of the papillary muscles. Top right: The time to peak circumferential 
velocities of the anterior, anterolateral, infero-lateral, inferior, inferoseptal and antero-septal walls (starting 
from 12 ‘O’ clock position and proceeding in a clockwise direction) are shown. In this VVI analysis, the 
max. circumferential wall dyssynchrony is 167ms. 
 
Figure 4. A bar diagram comparing the mean LVEF and SD of the obese subjects with and without 
longitudinal septal to lateral (S-L) wall delay of >75ms. 
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Table 1. Baseline demographic, clinical and laboratory data. 
 
 Variable Obese (n=74) Non-Obese (n=62) p value 
Age (in years) 53 + 13 57 + 18 0.13 
Male 22 (29%) 22 (35%) 0.58 
African-Americans 64 (86%) 40 (65%) <0.01 
Hypertension 57 (77%) 39 (63%) 0.09 
Diabetes Mellitus 26 (35%) 17 (27%) 0.36 
Hypercholesterolemia 20 (27%) 14 (23%) 0.69 
History of TIA or Stroke 3 (4%) 3 (5%) 0.54 
Smoker 18 (24%) 19 (31%) 0.44 
COPD 2 (3%) 4 (6%) 0.41 
Known OSA* 1 (1%) 3 (5%) 0.62 
On Hemodialysis 2 (3%) 4 (6%) 0.41 
Hemoglobin (g/dL) 11.9 + 2.5 12. + 1.7 0.56 
Creatinine (mg/dL) 1.4 + 1.4 1.8 + 2.7 0.26 
TIA=transient ischemic attack; OSA=obstructive sleep apnea; 
COPD=chronic obstructive pulmonary disease 
*Not all the study subjects had a sleep study to confirm OSA 
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Table 2. Baseline hemodynamic, echocardiographic and electrocardiographic data 
 
Variables Obese (n=74) Non-Obese (n=62) p value 
Hemodynamic Parameters 
Heart Rate (beats per minute) 79 + 15 81 + 17  0.66 
Systolic Blood Pressure (mm of Hg) 141 + 22 129 + 19 <0.01 
Diastolic Blood Pressure (mm of Hg) 79 + 12 73 + 10 <0.01 
Echocardiographic Parameters 
Ejection fraction (%) 60 + 7 61 + 8 0.22 
Pulmonary Artery Systolic Pressure (mm of Hg) 33 + 11 31 + 13 0.55 
Diastolic Dysfunction* (Grade 1) 51 (69%) 33 (53%) 0.08 
Left Atrial Diameter (cm) 3.5 + 0.6 3.4 + 0.6 0.48 
Left Ventricular Diastolic Dimension (cm) 4.8 + 0.5 4.5 + 0.5 <0.01 
Septal Wall Thickness (cm) 1.1 + 0.1 1 + 0.2 0.01 
Posterior Wall Thickness (cm) 1.1 + 0.2 1 + 0.2 <0.01 
Left Ventricular Mass (gms) 193 + 57 155 + 56 <0.01 
Left Ventricular Mass Index (LVMI) (gms/m2)   91 + 23 89 + 30 0.72 
Electrocardiographic Parameters 
QRS Duration (ms) 85 + 10 81 + 8 <0.01 
T-Wave Inversions 13 (18%) 16 (26%) 0.29 
Left Ventricular Hypertrophy** 8 (11%) 5 (8%) 0.77 
Q waves 1 (1%) 3 (5%) 0.32 
*None of the subjects had diastolic dysfunction greater than grade 1.  
**Based on Sokolow-Lyon or Cornell criteria. mm=millimeters; Hg=Mercury; cm=centimeters; 
ms=milliseconds; gms=grams 
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Table 3. Occurrence of dyssynchrony among obese and non-obese subjects 
 
Dyssynchrony Parameters Obese (n=74) Non-Obese (n=62) p value 
Longitudinal Dyssynchrony 
Septal to lateral (S-L) wall delay >75ms 7 (9.4%) 0 0.01 
Anterior to inferior (A-I) wall delay >75ms 6 (8.1%) 2 (3.2%) 0.20 
Maximum delay >100ms 31 (41.8%) 5 (8%) <0.01 
Longitudinal Strain Dyssynchrony 
S-L wall delay >75ms 23 (31%) 5 (8%) <0.01 
A-I wall delay >75ms 20 (27%) 10 (16.1%) 0.14 
Maximum delay >100ms 43 (58.1%) 21 (33.8%) <0.01 
Radial Dyssynchrony 
S-L wall delay >75ms 58 (78.3%) 24 (38.7%) <0.01 
A-I wall delay >75ms 60 (81%) 12 (19.3%) <0.01 
Maximum delay >100ms 67 (90.5%) 39 (62.9%) <0.01 
Circumferential Dyssynchrony 
Anterior to inferior wall (A-I) delay >100ms 12 (16.2%) 1 (1.6%) <0.01 
Anterolateral to Inferoseptal (AL-IS) wall delay >100ms 9 (12.1%) 1 (1.6%) 0.02 
Inferolateral to Anteroseptal (IL-AS) wall delay >100ms 12 (16.2%) 0 <0.01 
Maximum Delay >100ms 20(27%) 1 (1.6%) <0.01 
Circumferential Strain Dyssynchrony 
A-I wall delay >100ms 3 (4%) 0 0.25 
AL-IS wall delay >100ms 8 (10.8%) 1 (1.6%) 0.03 
IL-AS wall delay >100ms 3 (4%) 0 0.25 
Maximum Delay >100ms 8 (10.8%) 1 (1.6%) 0.03 
ms=milliseconds 
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Table 4. Comparison of dyssynchrony parameters between the obese and non-obese subjects using univariate 
analysis 
 
 
Dyssynchrony Parameters Obese (n=74) Non-Obese (n=62) p value 
Longitudinal Dyssynchrony (ms) 
Septal to lateral (S-L) wall delay  31 + 53 10 + 15 <0.01 
Anterior to inferior (A-I) wall delay  22 + 37 13 + 22 0.07 
Maximum delay 109 + 83 55 + 32 <0.01 
Longitudinal Strain Dyssynchrony (ms) 
S-L wall delay 69 + 88 29 + 33 <0.01 
A-I wall delay 55 + 62 34 + 41 0.01 
Maximum delay 134 + 84 86 + 54 <0.01 
Radial Dyssynchrony (ms) 
S-L wall delay 165 + 95 72 + 66 <0.01 
A-I wall delay 153 + 96 50 + 50 <0.01 
Maximum delay 255 + 105 133 + 78 <0.01 
Circumferential Dyssynchrony (ms) 
Anterior to inferior wall (A-I) delay 55 + 71 18 + 27 <0.01 
Anterolateral to Inferoseptal (AL-IS) wall delay 59 + 70 28 + 26 <0.01 
Inferolateral to Anteroseptal (IL-AS) wall delay 61 + 78 23 + 23 <0.01 
Maximum Delay 97 + 95 39 + 27 <0.01 
Circumferential Strain Dyssynchrony (ms) 
A-I wall delay 22 + 42 16 + 22 0.24 
AL-IS wall delay 30 + 48 20 + 31 0.16 
IL-AS wall delay 17 + 31 16 + 23 0.91 
Maximum Delay 44 + 53 29 + 32 0.04 
All data is presented as Mean + SD; ms=milliseconds 
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Table 5. Comparison of dyssynchrony parameters between obese and non-obese using multivariate* analysis 
 
Dyssynchrony Parameters Obese (n=74) Non-Obese (n=62) p value 
Longitudinal S-LWall Delay (ms) 31 + 53 10 + 15 <0.01 
Radial S-L Wall Delay (ms) 165 + 95 72 + 66 <0.01 
Circumferential Max. Opposing Wall Delay (ms) 97 + 95 39 + 27 0.01 
Longitudinal Strain S-L Wall Delay (ms) 69 + 88 29 + 33 <0.01 
Circumferential Strain Max. Opposing Wall Delay (ms) 44 + 53 29 + 32 0.88 
*adjusted for age, gender, race, LVEF, diastolic dysfunction, SWT, PWT, LVIDd, QRS duration, LV mass, 
LV mass index, systolic and diastolic blood pressure. S-L=Septal to Lateral; ms=millisecond 
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Table 6. Comparison of dyssynchrony parameters between morbidly obese and obese subjects using 
univariate analysis 
 
 
 
Dyssynchrony Parameters Morbidly Obese (n=24) Obese (n=50) p value 
Longitudinal Dyssynchrony (ms) 
Septal to lateral (S-L) wall delay  40 + 65 26 + 47 0.35 
Anterior to inferior (A-I) wall delay  23 + 35 22 + 38 0.89 
Maximum delay 125 + 98 101 + 74 0.29 
Longitudinal Strain Dyssynchrony (ms) 
S-L wall delay 70 + 73 68 + 95 0.92 
A-I wall delay 69 + 60 48 + 62 0.18 
Maximum delay 145 + 74 129 + 89 0.41 
Radial Dyssynchrony (ms) 
S-L wall delay 157 + 92 169 + 97 0.60 
A-I wall delay 195 + 96 134 + 91 0.01 
Maximum delay 279 + 113 244 + 100 0.19 
Circumferential Dyssynchrony (ms) 
Anterior to inferior wall (A-I) delay 51 + 59 57 + 76 0.69 
Anterolateral to Inferoseptal (AL-IS) wall delay 82 + 81 48 + 62 0.07 
Inferolateral to Anteroseptal (IL-AS) wall delay 54 + 63 64 + 84 0.55 
Maximum Delay 94 + 87 99 + 100 0.84 
Circumferential Strain Dyssynchrony (ms) 
A-I wall delay 36 + 63 16 + 25 0.14 
AL-IS wall delay 20 + 26 34 + 55 0.14 
IL-AS wall delay 17 + 29 17 + 32 0.97 
Maximum Delay 43 + 43 45 + 58 0.86 
All data presented as Mean + SD; ms=milliseconds 
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